Skip to main content

News

Filter

28/05/2024

The first antibiotic, not antibiotic, that saves lives.

Posted by Juan Basterra - 21/12/2023 It all begins with a small effort that can…
28/05/2024

Groundbreaking Study Reveals Definitive Link Between Gut Bacteria and Autism Spectrum Disorder (ASD)

Posted by Solana Pinilla - 21/12/2023 Scientists have achieved a major breakthrough in understanding autism…
14/05/2024

“The Economist, special Health”

An innovation, both in form and substance, is making headway in northern Spain. The pharmaceutical…
09/05/2024

Market Access Mentoring for Pymes from AseBio and Alira Health

Through a selection process, Mikrobiomik has been selected to participate in the Market Access Mentoring…
29/04/2024

We are launching a strategic investment round together with CaixaBank to launch MBK-01

Mikrobiomik has given CaixaBank CIB the exclusive mandate to assist in the search for potential…
17/04/2024

Improve people’s health through Compassionate Use

Posted by Solana Pinilla - 08/04/2024In an increasingly interconnected and technologically advanced world, health emerges…
08/03/2024

Celebrating Female Talent at Mikrobiomik

On Friday, March 8th, at Mikrobiomik, we took a moment to honor and celebrate the…
07/03/2024

Scientific Advisory in Santander

  On March 11th, took place the Mikrobiomik Scientific Advisory Board, a meeting that we…
18/01/2024

“Stories that Give Life” AseBio campaign

As part of the campaign promoted by AseBio (Spanish Association of Biotechnology Companies) called "Stories…
11/12/2023

Early closure of clinical trial ICD-01

On November 15th of this year, with our CRO "Sermes", we informed to the AEMPS…
26/09/2023

Mikrobiomik closes €1.1 million capital increase

On Wednesday, July 5, Mikrobiomik won the award for Best Idea/Project, after having reached the…
05/07/2023

Winners of the “Toribio Echevarría” for Best Idea/Project Award

On Wednesday, July 5, Mikrobiomik won the award for Best Idea/Project, after having reached the…
04/07/2023

Mikrobiomik chosen by Santander Bank among 1,800 SMEs

On Tuesday July 4th, Mikrobiomik was awarded with the “SME Bizkaia” prize in the category…
17/06/2023

I MIKROSALUD Workshop

The past Saturday June 17th took place in Bilbao the “I MIKROSALUD WORKSHOP”. The event…
16/06/2023

International Biotechnology Day Meeting

On the occasion of the celebration of the International Day of Biotechnology, we met at…
14/06/2023

AseBio annual report

AseBio's annual report 'Deep tech to transform the world'. The annual report on Spanish companies…
26/05/2023

Mikrobiomik showcase at the Pharma Partnering Summit

Mikrobiomik Showcase at the Pharma Partnering Summit in Munich. During the event that took place…
22/05/2023

Mikrobiomik focuses on Europe for 2025

Mikrobiomik seeks up to three million in a round and sets its focus on Europe…
10/05/2023

Mikrobiomik guest at the Congress of Health Logistics

Mikrobiomik special guest at the Congress of Health Logistics in Galicia. On May 9th, we…
28/03/2023

Agreement IRYCIS and Mikrobiomik

IRYCIS and Mikrobiomik sign an agreement for investigations related to the human microbiota.   Last…
28/02/2023

Mikrobiomik receives the award “Novel Company”.

On Monday, February 20th, the company was awarded with the "Novel Company" prize. This award…
02/10/2022

Mikrobiomik in the Business section of ABC

“Companies explore the future of the healthcare industry in gut microbiota” The Basque startup Mikrobiomik,…
13/09/2022

Interview on “Nacex” magazine

Interview with Juan Basterra CEO of the company. What is your differential value? The pharmaceutical…
27/07/2022

OSASUNBERRI, a project to support the health industry sector in the Basque Country

Mikrobiomik receives support from the Osasunberri program The official signing of the Basque Government's support…
10/06/2022

Mikrobiomik joins the Board of Directors of the Basque Health Cluster

Mikrobiomik will be part of the new Board of Directors of the Basque Health Cluster…
17/03/2022

Seed Capital Bizkaia takes 3% stake in shares of Mikrobiomik

Seed Capital Bizkaia takes 3% stake in shares of Mikrobiomik. Under its remit to promote…
12/01/2022

Mikrobiomik on television

Mikrobiomik on TV. Last weekend we had the pleasure of appearing on the ETB programme…
04/01/2021

Mikrobiomik receives major grants and subsidies

Since its launch, Mikrobiomik has received grants and subsidies amounting to over €600,000. Thanks to…
11/12/2020

Mikrobiomik, 2020 CEBEK Emprende Prize

Mikrobiomik is a bio-pharmaceutical company headquartered in Derio, near Bilbao (Spain) that belongs to the…
10/12/2020

CEBEK interview with Juan Basterra, CEO of Mikrobiomik

Juan Basterra, CEO of Mikrobiomik, has been interviewed for the CEBEK (Bizkaia Business Confederation) magazine.…
27/06/2019

Mikrobiomik reaches final of CEBEK Emprende awards

Mikrobiomik was shortlisted as a finalist for the 2nd CEBEK Emprende awards, sponsored by the…
09/05/2019

Mikrobiomik moves to BIC Bizkaia

Mikrobiomik moves to new premises at the BIC Bizkaia business incubator. Just a year after…
16/04/2019

Orza invests in Mikrobiomik

ORZA has shown its confidence in Mikrobiomik with a €400,000 investment as part of the…
05/09/2018

Mikrobiomik obtained SME rating from EMA

On 4 July 2018 the European Medicines Agency (EMA) granted an SME rating to Mikrobiomik.…